Cargando…
Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer
Treatment for advanced gastric cancer is challenging. Epidermal growth factor receptor (EGFR) contributes to the proliferation and development of gastric cancer (GC), and its overexpression is associated with unfavorable prognosis in GC. Cetuximab, a monoclonal antibody targeting EGFR, failed to imp...
Autores principales: | Ma, Huanrong, Wu, Jingjing, Zhou, Minyu, Wu, Jianhua, Wu, Zhenzhen, Lin, Li, Huang, Na, Liao, Wangjun, Sun, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488517/ https://www.ncbi.nlm.nih.gov/pubmed/34590499 http://dx.doi.org/10.1177/15347354211045349 |
Ejemplares similares
-
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
por: Huang, Na, et al.
Publicado: (2015) -
Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells
por: Li, Yang, et al.
Publicado: (2018) -
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer
por: Hu, Xingbin, et al.
Publicado: (2023) -
Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
por: DUAN, JIANGMAN, et al.
Publicado: (2016) -
XB130 promotes proliferation and invasion of gastric cancer cells
por: Shi, Min, et al.
Publicado: (2014)